Search
Search
About
Log in
Join
Experiences with
Enzalutamide
Posts
Communities
833 public posts
Filter results
My story - 16 years with metastatic prostate cancer - I’ve had just about everything
Modulated Radiotherapy - 81gy over three months 3.Zolodex - with a break in 2009 4.Zometa - lots at first, now every year or so 5.Cassodex - added to Zolodex for a short time - didn't help 6.Abiraterone - worked for almost 4 years (switching from prednisalone to dexamethasone extended its efficacy) 7.
Enzalutamide
Modulated Radiotherapy - 81gy over three months 3.Zolodex - with a break in 2009 4.Zometa - lots at first, now every year or so 5.Cassodex - added to Zolodex for a short time - didn't help 6.Abiraterone - worked for almost 4 years (switching from prednisalone to dexamethasone extended its efficacy) 7.
Enzalutamide
Hidden
in
Advanced Prostate Cancer
6 years ago
An Update To My Profile And Entering A New Phase In My Journey
; OR Patient must have developed intolerance to
enzalutamide
of a severity necessitating permanent treatment withdrawal.
; OR Patient must have developed intolerance to
enzalutamide
of a severity necessitating permanent treatment withdrawal.
BrianE
in
Advanced Prostate Cancer
6 years ago
latest published news
More positive news on fighting the beast. onward we go https://www.google.com/amp/s/www.medicalnewstoday.com/articles/amp/322311 https://www.google.com/amp/amp.timeinc.net/fortune/2018/06/28/
enzalutamide
-prostate-cancer-treatment https://eurekalert.org/pub_releases/2018-06/sonm-eto062618.php
More positive news on fighting the beast. onward we go https://www.google.com/amp/s/www.medicalnewstoday.com/articles/amp/322311 https://www.google.com/amp/amp.timeinc.net/fortune/2018/06/28/
enzalutamide
-prostate-cancer-treatment https://eurekalert.org/pub_releases/2018-06/sonm-eto062618.php
Fdmftmdl
in
Advanced Prostate Cancer
6 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
What next after chemo fails
The oncologist is very negative and implies that there are very few options remaining, he has not had Aberiterone but onc says this rarely works after
enzalutamide
fails because thay work in a similar way. Has anyone experienced this?
The oncologist is very negative and implies that there are very few options remaining, he has not had Aberiterone but onc says this rarely works after
enzalutamide
fails because thay work in a similar way. Has anyone experienced this?
JanJames
in
Advanced Prostate Cancer
6 years ago
Zenith Epigenetics Study Demonstrates Outstanding Results
In Phase 2, Zenith Epigenetics will be focused on continuing the evaluation of efficacy of ZEN-3694 in combination with
enzalutamide
(Xtandi).
In Phase 2, Zenith Epigenetics will be focused on continuing the evaluation of efficacy of ZEN-3694 in combination with
enzalutamide
(Xtandi).
Maxsayulita
in
Advanced Prostate Cancer
6 years ago
Trials NCT 03338790 or NCT02897375 Decided on NCT 03338790 trial
Anyone on either of this trials NCT 03338790 (An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or
Enzalutamide
in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD)) or NCT02897375 (Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Anyone on either of this trials NCT 03338790 (An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or
Enzalutamide
in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD)) or NCT02897375 (Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
cjkn2000
in
Advanced Prostate Cancer
6 years ago
What's my next line of defense?
At this point my next line of defense was to start a daily dose of Xtandi (
Enzalutamide
).
At this point my next line of defense was to start a daily dose of Xtandi (
Enzalutamide
).
MJStar
in
Advanced Prostate Cancer
6 years ago
Statin use and survival in metastatic castration-resistant PCa treated with abiraterone or enzalutamide after docetaxel failure.
"Five hundred and ninety-eight patients treated with second-line abiraterone or
enzalutamide
after docetaxel for mCRPC were included. A total of 199 men (33.3%) received statins during abiraterone/
enzalutamide
treatment.
"Five hundred and ninety-eight patients treated with second-line abiraterone or
enzalutamide
after docetaxel for mCRPC were included. A total of 199 men (33.3%) received statins during abiraterone/
enzalutamide
treatment.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Yonsa vs Zytiga
The STAAR trial included 53 patients with mCRPC who had not received prior Yonsa,
enzalutamide
, radium-223, or chemotherapy (unless it was docetaxel one or more year prior to study entry).
The STAAR trial included 53 patients with mCRPC who had not received prior Yonsa,
enzalutamide
, radium-223, or chemotherapy (unless it was docetaxel one or more year prior to study entry).
JLS1
in
Advanced Prostate Cancer
6 years ago
Tlow up from my last posting
Cabazitaxel (Jevatna),
Enzalutamide
(Xtnadi), Radium223 Clinical trial Olaparib, Olaparib+Cendirinib
Enzalutamide
+Atezolizumab If you gents read my last posting, you'll know where I left off. Also can anyone give me any personal experience on these other options. Thank you, Ralph
Cabazitaxel (Jevatna),
Enzalutamide
(Xtnadi), Radium223 Clinical trial Olaparib, Olaparib+Cendirinib
Enzalutamide
+Atezolizumab If you gents read my last posting, you'll know where I left off. Also can anyone give me any personal experience on these other options. Thank you, Ralph
RalphieJr64
in
Advanced Prostate Cancer
6 years ago
German clinics and Lu-177
I'm looking into both even though I just started on
Enzalutamide
(2-3 weeks in.. no idea if it's helping yet). I'm 50, diagnosed in Aug 2017 with seemingly aggressive (no biopsy, just PSA doubling time), androgen resistant stage four PCa (extensive mets through pelvis and spine).
I'm looking into both even though I just started on
Enzalutamide
(2-3 weeks in.. no idea if it's helping yet). I'm 50, diagnosed in Aug 2017 with seemingly aggressive (no biopsy, just PSA doubling time), androgen resistant stage four PCa (extensive mets through pelvis and spine).
Sriyantra
in
Advanced Prostate Cancer
6 years ago
EAU18 - Copenhagen. Castration Resistant PCa [CRPC]
The available data on abiraterone and
enzalutamide
support maintained efficacy in this setting. [1] Another recently published study assessed the effect the addition of
enzalutamide
had in MCRPC patients who progressed after 24 weeks with abiraterone. [2] The primary endpoint was radiographic progression
The available data on abiraterone and
enzalutamide
support maintained efficacy in this setting. [1] Another recently published study assessed the effect the addition of
enzalutamide
had in MCRPC patients who progressed after 24 weeks with abiraterone. [2] The primary endpoint was radiographic progression
pjoshea13
in
Advanced Prostate Cancer
6 years ago
EAU18 - Copenhagen. PROSPER Trial.
Maha Hussain presented the data from the PROSPER study, which was an incredibly important study looking at the role for
enzalutamide
(ENZA) in the setting of non-metastatic castration-resistant prostate cancer (nmCRPC).
Maha Hussain presented the data from the PROSPER study, which was an incredibly important study looking at the role for
enzalutamide
(ENZA) in the setting of non-metastatic castration-resistant prostate cancer (nmCRPC).
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Seeking input on Australia for Lu-177 for my dad
He has failed multiple rounds of chemo, hormone treatments (both abiraterone and
enzalutamide
). With his PSA at over 700 and overwhelming pain and weakness, he recently received his first dose of Lu-177. Fortunately, he seems to be responding well.
He has failed multiple rounds of chemo, hormone treatments (both abiraterone and
enzalutamide
). With his PSA at over 700 and overwhelming pain and weakness, he recently received his first dose of Lu-177. Fortunately, he seems to be responding well.
sandiegosmiles
in
Advanced Prostate Cancer
6 years ago
Testosterone metabolites inhibit proliferation of castration- and therapy-resistant PCa.
Abstract Novel treatments for castration-resistant prostate cancer (CRPC) such as abiraterone acetate (AA) or
enzalutamide
effectively target the androgen pathway to arrest aberrant signalling and cell proliferation. Testosterone is able to inhibit tumour cell growth in CRPC.
Abstract Novel treatments for castration-resistant prostate cancer (CRPC) such as abiraterone acetate (AA) or
enzalutamide
effectively target the androgen pathway to arrest aberrant signalling and cell proliferation. Testosterone is able to inhibit tumour cell growth in CRPC.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Enzalutamide resistance. What's next?
I am feeling very upset about this drug no longer working effectively and am hoping that there are some success stories with either resensitising to
enzalutamide
or more drugs.
I am feeling very upset about this drug no longer working effectively and am hoping that there are some success stories with either resensitising to
enzalutamide
or more drugs.
Ssiddy
in
Advanced Prostate Cancer
7 years ago
mcrpc , stage iv with aggressive treatments
right now he is following same Eligard 6 monthly and instead of bicalutamide he was prescribed 3 tablets
enzalutamide
daily. Fingers crossed .. will keep updating.Wish everyone all the courage and blessings to fight it out.
right now he is following same Eligard 6 monthly and instead of bicalutamide he was prescribed 3 tablets
enzalutamide
daily. Fingers crossed .. will keep updating.Wish everyone all the courage and blessings to fight it out.
caretkr
in
Advanced Prostate Cancer
6 years ago
It's Half Time at the Chemo Bowl - I am in front right now
MO advises that next treatments are likely to be hormonal - abiraterone or
enzalutamide
I guess. But since I am already hormone-independent I don't know how much this will help. Since I failed ADT within 3 months I asked MO if I have ARV7 splice variant.
MO advises that next treatments are likely to be hormonal - abiraterone or
enzalutamide
I guess. But since I am already hormone-independent I don't know how much this will help. Since I failed ADT within 3 months I asked MO if I have ARV7 splice variant.
Hazard
in
Advanced Prostate Cancer
6 years ago
[177Lu]-PSMA-617 Has Activity in Castration-Resistant Prostate Cancer
Violet, and colleagues evaluated the efficacy and safety of LuPSMA in a prospective phase II trial of 30 patients with metastatic castration-resistant prostate cancer who had progressed after standard therapies including taxane-based chemotherapy and second-generation antiandrogens (abiraterone or
enzalutamide
Violet, and colleagues evaluated the efficacy and safety of LuPSMA in a prospective phase II trial of 30 patients with metastatic castration-resistant prostate cancer who had progressed after standard therapies including taxane-based chemotherapy and second-generation antiandrogens (abiraterone or
enzalutamide
tango65
in
Advanced Prostate Cancer
6 years ago
Cross-resistance between Ethinylestradiol and Enzalutamide
Cross-resistance between ethinylestradiol and
enzalutamide
was clearly observed in the setting of pre-docetaxel. In multivariate analysis, the T stage and number of therapies before
enzalutamide
were the only significant predictors of prostate-specific antigen response to
enzalutamide
.
Cross-resistance between ethinylestradiol and
enzalutamide
was clearly observed in the setting of pre-docetaxel. In multivariate analysis, the T stage and number of therapies before
enzalutamide
were the only significant predictors of prostate-specific antigen response to
enzalutamide
.
pjoshea13
in
Advanced Prostate Cancer
7 years ago
1
...
36
37
38
...
42
Next page
10
20
30
40
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
760 results
Fight Prostate Cancer
56 results
Prostate Cancer Network
7 results
View top 10 communities
Sort by
Most Relevant
Newest